Xencor Inc (XNCR)
19.24
+0.22
(+1.16%)
USD |
NASDAQ |
Apr 25, 16:00
19.24
0.00 (0.00%)
After-Hours: 16:56
Xencor Free Cash Flow: 63.86M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 63.86M |
| September 30, 2023 | -150.97M |
| June 30, 2023 | -136.30M |
| March 31, 2023 | -63.54M |
| December 31, 2022 | -18.92M |
| September 30, 2022 | 71.55M |
| June 30, 2022 | 44.79M |
| March 31, 2022 | 1.975M |
| December 31, 2021 | -32.83M |
| September 30, 2021 | -75.12M |
| June 30, 2021 | -41.57M |
| March 31, 2021 | -57.61M |
| December 31, 2020 | -18.77M |
| September 30, 2020 | -54.86M |
| June 30, 2020 | -55.44M |
| March 31, 2020 | 80.38M |
| December 31, 2019 | 53.34M |
| September 30, 2019 | 56.38M |
| June 30, 2019 | 54.46M |
| March 31, 2019 | -82.12M |
| December 31, 2018 | -88.90M |
| Date | Value |
|---|---|
| September 30, 2018 | -77.29M |
| June 30, 2018 | -72.07M |
| March 31, 2018 | -56.11M |
| December 31, 2017 | -40.88M |
| September 30, 2017 | -48.02M |
| June 30, 2017 | 91.38M |
| March 31, 2017 | 95.45M |
| December 31, 2016 | 92.23M |
| September 30, 2016 | 103.39M |
| June 30, 2016 | 9.107M |
| March 31, 2016 | 11.27M |
| December 31, 2015 | 22.99M |
| September 30, 2015 | 21.12M |
| June 30, 2015 | -22.78M |
| March 31, 2015 | -21.43M |
| December 31, 2014 | -23.64M |
| September 30, 2014 | -21.34M |
| June 30, 2014 | -20.55M |
| March 31, 2014 | -13.28M |
| December 31, 2013 | -6.747M |
Free Cash Flow Range, Past 5 Years
-150.97M
Minimum
Sep 2023
80.38M
Maximum
Mar 2020
-14.70M
Average
-18.92M
Median
Dec 2022
Free Cash Flow Benchmarks
| Ionis Pharmaceuticals Inc | -335.52M |
| Karyopharm Therapeutics Inc | -92.72M |
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 181.21M |
| Cash from Investing (Quarterly) | -203.13M |
| Cash from Financing (Quarterly) | 22.98M |
| Free Cash Flow Per Share (Quarterly) | 2.950 |
| Free Cash Flow to Equity (Quarterly) | 158.53M |
| Free Cash Flow to Firm (Quarterly) | 179.50M |
| Free Cash Flow Yield | 5.51% |